Patent ID: 6537981
Filing Date: 2003-03-25
Classification: A61P,C07C,C07F,Y02P

Abstract:
A method of treating metabolic bone disease where it is desired to maintain or increase bone mass comprising administering to a patient with said disease an effective amount of a compound selected from the group consisting of20(S)-1&agr;,25-dihydroxy-2-methylene-26,27-dihomo-19-norvitamin D3, 20(S)-26,27-dimethylene-25-methoxy-2-methylene-19-norvitamin D3, 20(S)-1&agr;,25-dihydroxy-26,27-dimethylene-2-methylene-19-norvitamin D3, and 20(S)-26,27-dimethylene-1&agr;-hydroxy-2-methylene-24-dehydro-19-norvitamin D3.